The ambitious and large-scale startup of "Rubius Therapeutics" has collected three components of the successful project recently. It is money of large investors of $120 million, collective from scientists, doctors and managers, plus about 100 million more dollars of donations from the interested first clients. The technology of creation of "superblood" – almost universal remedy of treatment of many diseases has to become result.
The concept of superblood is based on the existing technique of use of T-lymphocytes for strengthening of the immune answer of a human body. If instead of a lymphocyte to take an erythrocyte and to add to him highly specialized white, and then to enter these modified cages into blood of the person, he will receive a concrete disease medicine. For example, it is so possible to compensate the shortage of some enzymes and to cure to a wolf cub, diabetes of the 1st type or some forms of cancer.
Oh my, this is unreal. Thanks for sharing.